| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.46B | +13.4% |
| Cost of Revenue | $272.1M | +16.0% |
| Gross Profit | $1.19B | +12.8% |
| R&D Expense | $340.1M | +1.0% |
| SG&A Expense | $281.9M | +1.5% |
| Operating Income | -$80.6M | +53.7% |
| Pre-tax Income | $30.4M | +215.5% |
| Income Tax | $6.6M | +158.3% |
| Net Income | $23.8M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.04B | +5.3% |
| Accounts Receivable | $32.3M | +15.3% |
| Current Assets | $7.24B | +14.6% |
| Total Assets | $10.06B | +9.6% |
| Current Liabilities | $4.59B | +12.9% |
| Long-term Debt | $1.71B | +87.6% |
| Total Liabilities | $6.15B | +21.9% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $350.6M | +25.8% |
| Capital Expenditures | $4.3M | +344.2% |
| Investing Cash Flow | -$817.4M | -99.7% |
| Financing Cash Flow | $666.5M | +189.8% |
| Free Cash Flow | $346.3M | +24.7% |
| +182.4% |
| EPS (Basic) | $0.23 | +185.2% |
| EPS (Diluted) | -$0.07 | +74.1% |
| Stockholders' Equity |
| $3.91B |
| -5.3% |